Aliases & Classifications for Cleft Lip

About this section

Aliases & Descriptions for Cleft Lip:

Name: Cleft Lip 11 50 39 13
Cleft Lip, Unilateral, Complete 11
Complete Unilateral Cleft Lip 11
 
Labium Leporinum 11
Cheiloschisis 11
Hare Lip 11

Classifications:



External Ids:

Disease Ontology11 DOID:9296
ICD1030 Q36, Q36.9
MeSH39 D002971
NCIt45 C87175

Summaries for Cleft Lip

About this section
MalaCards based summary: Cleft Lip, also known as cleft lip, unilateral, complete, is related to cleft lip/palate and cleft lip/palate-ectodermal dysplasia syndrome. An important gene associated with Cleft Lip is MSX1 (Msh Homeobox 1), and among its related pathways are TP53 network and Angiogenesis (CST). Affiliated tissues include bone, brain and heart, and related mouse phenotypes are Increased shRNA abundance (Z-score > 2) and muscle.

Related Diseases for Cleft Lip

About this section

Diseases related to Cleft Lip via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 272)
idRelated DiseaseScoreTop Affiliating Genes
1cleft lip/palate12.5
2cleft lip/palate-ectodermal dysplasia syndrome12.4
3cleft lip +/- cleft palate12.3
4ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 312.2
5coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or mental retardation12.2
6isolated cleft lip12.1
7cleft lip and alveolus12.1
8median cleft lip/mandibule12.0
9arthrogryposis, ectodermal dysplasia, cleft lip/palate, and developmental delay12.0
10orofacial cleft 1112.0
11hay-wells syndrome11.9
12cleft lip/palate with abnormal thumbs and microcephaly11.9
13coloboma, cleft lip/palate and mental retardation syndrome11.9
14polydactyly cleft lip palate psychomotor retardation11.9
15van der woude syndrome11.9
16ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 111.9
17cleft lip/palate with characteristic facies, intestinal malrotation, and lethal congenital heart disease11.9
18microcephaly, corpus callosum dysgenesis and cleft lip-palate11.9
19cleft lip, congenital healed11.9
20amelia cleft lip palate hydrocephalus iris coloboma11.8
21anophthalmia cleft lip palate hypothalamic disorder11.8
22cleft lip and palate malrotation cardiopathy11.8
23cleft lip and/or palate with mucous cysts of lower11.8
24cleft lip palate dysmorphism kumar type11.8
25cleft lip palate mental retardation corneal opacity11.8
26cleft lip palate oligodontia syndactyly pili torti11.8
27cleft lip palate pituitary deficiency11.8
28cleft lip palate-tetraphocomelia11.8
29craniosynostosis cleft lip palate arthrogryposis11.8
30holoprosencephaly ectrodactyly cleft lip palate11.8
31lagophthalmia cleft lip palate11.8
32microbrachycephaly ptosis cleft lip11.8
33multiple congenital anomalies mental retardation, growth failure and cleft lip palate11.8
34syndactyly ectodermal dysplasia cleft lip palate hand foot11.8
35tibial hemimelia cleft lip palate11.8
36cleft lip/palate-deafness-sacral lipoma syndrome11.8
37cleft lip-retinopathy syndrome11.8
38short stature-intellectual disability-eye anomalies-cleft lip/palate syndrome11.8
39auriculoocular anomalies-cleft lip syndrome11.8
40auricular abnormalities-cleft lip with or without cleft palate-ocular abnormalities syndrome11.8
41eec syndrome11.8
42rapp-hodgkin syndrome11.8
43roberts syndrome11.7
44hartsfield syndrome11.7
45popliteal pterygium syndrome 111.6
46orofacial cleft 611.6
47orofacial cleft 511.6
48orofacial cleft 1011.6
49vici syndrome11.6
50blepharocheilodontic syndrome11.6

Graphical network of the top 20 diseases related to Cleft Lip:



Diseases related to cleft lip

Symptoms & Phenotypes for Cleft Lip

About this section

GenomeRNAi Phenotypes related to Cleft Lip according to GeneCards Suite gene sharing:

26
idDescriptionGenomeRNAi Source AccessionScoreTop Affiliating Genes
1GR00366-A-359.6FGFR1, IRF6, TFAP2A, TGFA

MGI Mouse Phenotypes related to Cleft Lip according to GeneCards Suite gene sharing:

41 (show all 13)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053699.4BMP4, FGFR1, MID1, MSX1, PAX9, TGFA
2MP:00053779.3BMP4, FGFR1, IRF6, MSX1, PAX9, TBX10
3MP:00053808.9BMP4, FGFR1, IRF6, MID1, MSX1, PAX9
4MP:00053718.7BMP4, FGFR1, IRF6, MSX1, MTHFR, PAX9
5MP:00107718.6BMP4, FGFR1, IRF6, MSX1, MTHFR, NECTIN1
6MP:00028738.6BMP4, FGFR1, MID1, PAX9, SUMO1, TBX10
7MP:00053908.5BMP4, FGFR1, IRF6, MSX1, MTHFR, PAX9
8MP:00053868.4BMP4, FGFR1, MID1, MSX1, NECTIN1, PAX9
9MP:00053918.3BMP4, FGFR1, MSX1, MTHFR, NECTIN1, TBX10
10MP:00053817.8BMP4, FGFR1, IRF6, MSX1, PAX9, SUMO1
11MP:00053827.8BMP4, FGFR1, IRF6, MSX1, NECTIN1, PAX9
12MP:00107687.3BMP4, FGFR1, IRF6, MID1, MSX1, MTHFR
13MP:00053787.1BMP4, FGFR1, IRF6, MID1, MSX1, MTHFR

Drugs & Therapeutics for Cleft Lip

About this section

Drugs for Cleft Lip (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 76)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Amoxicillinapproved, vet_approvedPhase 444126787-78-033613, 2171
Synonyms:
(-)-6-(2-Amino-2-(P-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo-(3.2.0)heptane-2-carboxylic acid
(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
26787-78-0
33911-69-2
34642-77-8 (mono-hydrochloride salt)
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2-amino-2-(p-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-, D- (8CI)
6-(D-(-)-alpha-Amino-p-hydroxyphenylacetamido)penicillanic acid
6-(D-(-)-p-Hydroxy-alpha-aminobenzyl)penicillin
6-(P-Hydroxy-alpha-aminophenylacetamido)penicillanic acid
6-(a-Amino-4-hydroxyphenylacetamido)penicillanic acid
6-(p-Hydroxy-alpha-aminophenylacetamido)penicillanic acid
6-(p-hydroxy-α-aminophenylacetamido)penicillanic acid
6-[[Amino(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 9CI
61336-70-7 (TRIHYDRATE)
6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carbonyl
6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carboxylic acid
71447-36-4
81030-75-3
AC-12263
AC1L1PY2
AMC
AMOXICILLIN CRYSTALLINE
AMOXICILLIN PEDIATRIC
AMPC
AUGMENTIN '125'
AUGMENTIN '200'
AUGMENTIN '250'
AUGMENTIN '400'
AUGMENTIN '500'
AUGMENTIN '875'
AUGMENTIN ES-600
AX
Actimoxi
Almodan
Ambap26787-78-0
Amix
Amoclen
Amolin
Amopen
Amopenixin
Amoram
Amox
Amox 250 Cap 250mg
Amox 500 Cap 500mg
Amox S 125 Sus 125mg/5ml
Amox S 250 Sus 250mg/5ml
Amoxi
Amoxi-Mast
Amoxi-mast
Amoxibiotic
Amoxicaps
Amoxicilina
Amoxicilina [INN-Spanish]
Amoxicillin (INN)
Amoxicillin (TN)
Amoxicillin (anhydrous)
Amoxicillin (inn)
Amoxicillin Trihydrate
Amoxicillin and clavulanate potassium
Amoxicillin anhydrous
Amoxicillin pediatric
Amoxicillin trihydrate
Amoxicillin(usan)
Amoxicilline
Amoxicilline [INN-French]
Amoxicilline [INN]
Amoxicilline [inn]
Amoxicillinum
Amoxicillinum [INN-Latin]
Amoxid
Amoxiden
Amoxil
Amoxivet
Amoxycillin
Amoxycillin Trihydrate
Amoxycillin trihydrate
Amoxycillin, BAN
Amoxymed
Amrit
Anemolin
Apo-Amoxi
Apo-Amoxi Cap 250mg
Apo-Amoxi Cap 500mg
Apo-Amoxi Pwr for Susp 125mg/5ml
Apo-Amoxi Pwr for Susp 250mg/5ml
Apo-amoxi
Apo-amoxi sugar free
Aspenil
BL-P 1410
BLP 1410
BPBio1_000499
BRD-K55044200-001-03-9
BRL 2333
BRL-2333
BSPBio_000453
 
Biomox
Bristamox
C06827
CHEBI:2676
CHEBI:53712
CHEMBL1082
CID33613
CPD000058707
Cemoxin
Clamoxyl
Clamoxyl (SKB)
D-(-)-alpha-Amino-p-hydroxybenzyl penicillin
D-(-)-alpha-Amino-p-hydroxybenzylpenicillin
D-(alpha-Amino-p-hydroxybenzyl)penicillin
D-2-Amino-2-(4-hydroxyphenyl)acetamidopenicillanic acid
D-Amoxicillin
D07452
DB01060
Delacillin
DisperMox
Dispermox
EINECS 248-003-8
Efpenix
Flemoxin
Galenamox
Gen-Amoxicillin 250mg
Gen-Amoxicillin 500mg
HMS1569G15
HSDB 3204
Hiconcil
Histocillin
Hydroxyampicillin
Ibiamox
Imacillin
LS-149721
Lamoxy
Larotid
MLS000028632
MLS002222248
Metafarma capsules
Metifarma capsules
MolPort-003-981-182
MolPort-005-933-687
Moxacin
Moxal
Moxatag
NCGC00179554-01
NSC 277174
NSC277174
Novamoxin Cap 250mg
Novamoxin Cap 500mg
Novamoxin Sus 125mg/5ml
Novamoxin Sus 250mg/5ml
Nu-Amoxi Cap 250mg
Nu-Amoxi Cap 500mg
Nu-Amoxi Sus 125/5ml
Nu-Amoxi Sus 250mg/5ml
Ospamox
P-Hydroxyampicillin
PHL-amoxicillin
PMS-amoxicillin
Pamoxicillin
Piramox
Polymox
Prestwick0_000357
Prestwick1_000357
Prestwick2_000357
Prestwick3_000357
Prestwick_713
Prevpac
Pro Amox Pwr for Oral Susp 125mg/5ml
Pro Amox-250 Cap 250mg
Pro Amox-500 Cap 500mg
Pro-Amox-250 Orl Sus 250mg/5ml
R-Hydroxyampicillin
Rimoxallin
Ro 10-8756
Robamox
SAM002264592
SMR000058707
SPBio_002374
Sauracillin
Sawamox PM
Sumox
Tolodina
Trimox
Unicillin
Utimox
Vetramox
Wymox
Zimox
alpha-Amino-p-hydroxybenzylpenicillin
alpha-amino-P-Hydroxybenzylpenicillin
amoxicillanyl
amoxicillin
p-Hydroxyampicillin
α-amino-p-hydroxybenzylpenicillin
2Anti-Infective AgentsPhase 4, Phase 2, Phase 121402
3Anti-Bacterial AgentsPhase 4, Phase 110884
4Antibiotics, AntitubercularPhase 4, Phase 16972
5Antitubercular AgentsPhase 41272
6
AcetylcholineapprovedPhase 3, Phase 1, Phase 277651-84-3187
Synonyms:
ACh
Acetyl choline ion
Acetylcholine Chloride
Acetylcholine cation
 
Acetylcholinium: acetyl-Choline
Choline acetate
Choline acetate (ester)
O-Acetylcholine
acetylcholine chloride
7
LevobupivacaineapprovedPhase 2, Phase 316527262-47-192253
Synonyms:
(-)-Bupivacaine
(-)-bupivacaine
(2S)-1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
(S)-1-Butyl-2',6'-pipecoloxylidide
(S)-Bupivacaine
(S)-bupivacaine
27262-47-1
27262-48-2
AC1L3NQM
BIDD:GT0471
C07887
C18H28N2O
CAS-18010-40-7
CHEBI:6149
CID92253
D08116
 
DB01002
L(-)-Bupivacaine
L-(-)-1-Butyl-2',6'-pipecoloxylidide
L-(-)-Bupivacaine
L-(-)-bupivacaine
LS-109843
LS-187025
LS-187789
Levobupivacaine
Levobupivacaine (INN)
Levobupivacaine [INN:BAN]
Levobupivacaine hydrochloride
MolPort-004-959-713
NCGC00016733-01
NCGC00159482-02
Novabupi
Novabupi (TN)
8
Bupivacaineapproved, investigationalPhase 2, Phase 311312180-92-9, 38396-39-32474
Synonyms:
( inverted exclamation markA)-bupivacaine
(+-)-Bupivacaine
(1)-1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
(RS)-bupivacaine
(±)-bupivacaine
1-Butyl-2',6'-pipecoloxylidide
1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
15233-43-9
2180-92-9
38396-39-3
AB00053674
AC-2096
AC1L1DRE
AC1Q5LX4
AH 250
AKOS001637202
AR-1A0242
Anekain
BPBio1_000298
BRD-A01636364-003-05-2
BSPBio_000270
BSPBio_002607
Bio-0886
Bloqueina
Bucaine
Bucaine (TN)
Bupivacaina
Bupivacaina [INN-Spanish]
Bupivacaine (INN)
Bupivacaine Carbonate
Bupivacaine HCL
Bupivacaine HCL KIT
Bupivacaine Monohydrochloride, Monohydrate
Bupivacaine [INN:BAN]
Bupivacainum
Bupivacainum [INN-Latin]
Bupivan
C07529
C18H28N2O
CBupivacaine
CHEBI:3215
CHEMBL1098
CID2474
Carbostesin
D07552
DB00297
DL-Bupivacaine
DUR-843
 
DepoBupivacaine
DivK1c_000758
EINECS 218-553-3
EINECS 253-911-2
HMS2090F12
IDI1_000758
KBio1_000758
KBio2_002004
KBio2_004572
KBio2_007140
KBio3_001827
KBioGR_001516
KBioSS_002004
KST-1A4609
L000695
LAC-43
LS-109841
LS-2222
MLS001361336
Marcaina
Marcaine
Marcaine HCL
Marcaine Spinal
MolPort-004-955-820
NCGC00178579-01
NCGC00178579-02
NINDS_000758
NSC119660
Prestwick0_000305
Prestwick1_000305
Prestwick2_000305
Prestwick3_000305
SMR000058218
SPBio_001558
SPBio_002489
Sensorcaine
Sensorcaine-MPF
Sensorcaine-MPF Spinal
Spectrum2_001589
Spectrum3_000974
Spectrum4_001098
Spectrum5_001483
Spectrum_001524
Transdur-Bupivacaine
UNII-Y8335394RO
Win 11318
Win 11318 HCl
bupivacaine
cBupivacaine
dl-1-Butyl-2',6'-pipecoloxylidide
racemic bupivacaine
9
Fentanylapproved, illicit, investigational, vet_approvedPhase 3773437-38-73345
Synonyms:
1-Phenethyl-4-(N-phenylpropionamido)piperidine
1-Phenethyl-4-N-propionylanilinopiperidine
1-phenethyl-4-N-propionylanilinopiperidine
437-38-7
5-22-08-00049 (Beilstein Handbook Reference)
80832-90-2
990-73-8 (citrate)
AC1L1FQ2
Actiq
BIDD:GT0555
BRN 0494484
CHEBI:119915
CHEMBL596
CID3345
D00320
DB00813
Duragesic
Duragesic (TN)
Duragesic-100
Duragesic-12
Duragesic-25
Duragesic-50
Duragesic-75
Durogesic
EINECS 207-113-6
Fentanest
Fentanil
Fentanil [DCIT]
Fentanila
Fentanila [INN-Spanish]
Fentanilo
Fentanyl
Fentanyl (JAN/USAN/INN)
Fentanyl CII
Fentanyl [INN:BAN]
Fentanyl citrate
Fentanyl-100
Fentanyl-12
Fentanyl-25
 
Fentanyl-50
Fentanyl-75
Fentanylum
Fentanylum [INN-Latin]
HSDB 3329
IONSYS
JNS020QD
L001275
LS-124439
Matrifen
MolPort-003-847-369
N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide
N-(1-Phenethyl-4-piperidyl)propionanilide
N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide
N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide
N-(1-phenethyl-4-piperidinyl)-N-phenylpropionamide
N-(1-phenethyl-4-piperidyl)propionanilide
N-(1-phenethylpiperidin-4-yl)-N-phenylpropanamide
N-(1-phenethylpiperidin-4-yl)-N-phenylpropionamide
N-Phenethyl-4-(N-propionylanilino)piperidine
N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide
N-phenethyl-4-(N-propionylanilino)piperidine
N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide
N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide
NCGC00168252-01
Nasalfent
Oprea1_152073
Oprea1_207148
PDSP1_000860
PDSP2_000846
Pentanyl
Phentanyl
Propanamide, N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)- (9CI)
R 4263
Rapinyl
Sentonil
Sublimase
Sublimaze
UNII-UF599785JZ
fentanyl
10
Ketamineapproved, vet_approvedPhase 2, Phase 35286740-88-13821
Synonyms:
(+-)-Ketamine
(+/-)-2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone
(+/-)-2-(o-Chlorophenyl)-2-(methylamino)cyclohexanone
(+/-)-Ketamine
(-)-Ketamine
(S)-(-)-Ketamine
(S)-Ketamine
(±)-ketamine
100477-72-3
2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone
2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone
2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one
2-(Methylamino)-2-(2-chlorophenyl)cyclohexanone
2-(methylamino)-2-(2-chlorophenyl)cyclohexanone
2-(o-Chlorophenyl)-2-(methylamino)-cyclohexanone
2-(o-Chlorophenyl)-2-(methylamino)cyclohexanone
2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone
33643-45-7
6740-88-1
79499-51-7
AC1L1GSH
AC1Q40UR
AKOS001053247
BRN 2216965
C07525
C13H16ClNO
CHEBI:138833
CHEBI:6121
CHEMBL742
CI 581 base
CI-581
CID3821
CLSTA 20
Calypsol
Cetamina
Cetamina [INN-Spanish]
Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)- (9CI)
Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-, (+-)- (9CI)
Cyclohexanone, 2-(o-chlorophenyl)-2-(methylamino)-, (+/-)- (8CI)
D08098
DB01221
DEA No. 7285
 
DL-ketamine
DivK1c_000217
EINECS 229-804-1
Esketamine
Green
IDI1_000217
KBio1_000217
KETAMINE
KETAMINE HCL
Ketaject
Ketalar
Ketalar base
Ketamina
Ketamine (INN)
Ketamine Base
Ketamine HCL
Ketamine [INN:BAN]
Ketaminum
Ketaminum [INN-Latin]
Ketanest
Ketoject
Ketolar
L-Ketamine
LS-57301
MLS001331674
MolPort-001-838-070
NCGC00159480-02
NCGC00159480-03
NINDS_000217
NMDA
NSC 70151
NSC70151
SMR000238141
Special K
Special K [street name]
Special k
T385
Tekam
Tekam (TN)
UNII-690G0D6V8H
dl-Ketamine
ketamine
l-Ketamine
11
Folic Acidapproved, nutraceutical, vet_approvedPhase 3427959-30-36037
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
AI3-26387
AKOS000503224
ARONIS014410
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
Antianemia factor
Apo-Folic
BIDD:ER0563
BIDD:GT0641
BIF0608
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
FOL
Facid
Factor U
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
Folsaeure
 
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
Incafolic
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
LS-2157
Liver Lactobacillus casei factor
MLS001304016
MLS001335861
Millafol
Mission prenatal
Mittafol
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-Pteroyl-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
NINDS_000494
NSC 3073
Nifolin
Nifolin [Denmark]
Novofolacid
Novofolacid [Canada]
PGA
PGA (VAN)
Prestwick3_000627
Prestwick_230
PteGlu
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylglutamate
Pteroylglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
SMP2_000137
SMR000471860
SPBio_001357
SPECTRUM1502020
Serum Folate Level
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
Spectrum_001381
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
bmse000299
folic acid
nchembio.108-comp10
12MicronutrientsPhase 35802
13HematinicsPhase 31630
14Trace ElementsPhase 35802
15Liver ExtractsPhase 3, Phase 2, Phase 13868
16Vitamin B ComplexPhase 34229
17VitaminsPhase 35095
18onabotulinumtoxinAPhase 3, Phase 1, Phase 2626
19Botulinum Toxins, Type APhase 3, Phase 1, Phase 2630
20Botulinum ToxinsPhase 3, Phase 1, Phase 2669
21abobotulinumtoxinAPhase 3, Phase 1, Phase 2626
22Cholinergic AgentsPhase 3, Phase 1, Phase 23846
23incobotulinumtoxinAPhase 3, Phase 1, Phase 2635
24Peripheral Nervous System AgentsPhase 3, Phase 2, Phase 122776
25Neurotransmitter AgentsPhase 3, Phase 2, Phase 117734
26Neuromuscular AgentsPhase 3, Phase 1, Phase 21129
27Excitatory Amino AcidsPhase 2, Phase 31297
28pancreatic polypeptidePhase 320
29Excitatory Amino Acid AntagonistsPhase 2, Phase 31282
30NarcoticsPhase 33486
31Adjuvants, AnesthesiaPhase 31588
32Analgesics, OpioidPhase 33091
33AnestheticsPhase 2, Phase 39001
34Central Nervous System DepressantsPhase 2, Phase 312806
35AnalgesicsPhase 2, Phase 311287
36Anesthetics, DissociativePhase 2, Phase 3507
37Anesthetics, GeneralPhase 2, Phase 32787
38Anesthetics, LocalPhase 2, Phase 33272
39Anesthetics, IntravenousPhase 2, Phase 32406
40Folinic AcidNutraceuticalPhase 33150
41FolateNutraceuticalPhase 34279
42Vitamin B9NutraceuticalPhase 34279
43ColaNutraceuticalPhase 3, Phase 2, Phase 11881
44
IndinavirapprovedPhase 2110150378-17-95362440
Synonyms:
(1(1S,2R),5(S))-2,3,5-Trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-D-erythro-Pentonamide
(1(1S,2R),5(S))-2,3,5-Trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-D-erythro-pentonamide
(2S)-1-[(2S,4S)-4-benzyl-2-hydroxy-5-[[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino]-5-oxopentyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide
150378-17-9
157810-81-6
157810-81-6 (sulfate (1:1) (salt))
166746-42-5
1c6y
1hsg
1hsh
1k6c
1sdt
1sdu
1sdv
1sgu
216884-06-9
2avo
2avs
2avv
2bpx
AC-20034
AC1L1U7I
AKOS000280989
BIDD:GT0378
BIDD:PXR0141
C07051
 
C36H47N5O4
CHEBI:44032
Compound J
Crixivan
Crixivan (TM)
DB00224
IDV
Indinavir (*1:1 Sulfate salt*)
Indinavir [USAN]
Indinavir anhydrous
Indinavir sulfate
Indinavir sulphate
Indinavir, Sulfate (1:1)
L 735524
L-735 524
L-735,524
L-735524
LS-173382
MK-639
MolPort-000-883-804
N-[2(R)-HYDROXY-1(S)-INDANYL]-5-[(2(S)-TERTIARY BUTYLAMINOCARBONYL)-4(3-PYRIDYLMETHYL)PIPERAZINO]-4(S)-HYDROXY-2(R)-PHENYLMETHYLPENTANAMIDE
NCGC00159460-02
NSC697197
Propolis & 4-Hydroxy-N-(2-hydroxy-2,3-dihydro-1H-1-indanyl)-N'-(1,1-dimethylethyl)-2-phenylmethyl-5-[4-(3-pyridylmethyl)-1-piperzinyl]hexanediamide
Propolis+Indinavir
RS-253
UNII-9MG78X43ZT
indinavir
45
Ritonavirapproved, investigationalPhase 2870155213-67-5392622
Synonyms:
1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate
155213-67-5
1hxw
1sh9
5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S)-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate
5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate
538, ABT
A-84538
ABBOTT-84538
ABT 538
ABT 84538
ABT-538
ABT538
AC-733
AC1L94GB
AKOS000280930
Abbott 84538
BIDD:GT0387
BIDD:PXR0023
Bio-0093
C07240
C37H48N6O5S2
CHEBI:45409
CHEMBL163
CID392622
CPD000466395
D00427
D019438
 
DB00503
DRG-0244
FT-0082824
HMS2051B08
HSDB 7160
LS-148860
MLS000759541
MLS001424063
MolPort-000-883-877
N-[(2S,4S,5S)-4-hydroxy-1,6-diphenyl-5-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}hexan-2-yl]-N~2~-(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl)-L-valinamide
NCGC00159462-02
NSC693184
Norvir
Norvir (TM)
Norvir (TN)
Norvir Sec
RIT
RTV
Ritonavir
Ritonavir (JAN/USAN/INN)
Ritonavir [USAN]
Ritonavir is an inhibitor of HIV protease used to treat HIV infection and AIDS.
Ritonavirum
S1185_Selleck
SAM001246783
SMR000466395
STK634209
ZINC03944422
ritonavir
46HIV Protease InhibitorsPhase 25319
47
protease inhibitorsPhase 25320
Synonyms:
 
protease inhibitors
48Cytochrome P-450 CYP3A InhibitorsPhase 21666
49Anti-HIV AgentsPhase 23100
50Cytochrome P-450 Enzyme InhibitorsPhase 23822

Interventional clinical trials:

(show top 50)    (show all 57)
idNameStatusNCT IDPhase
1The Role of Antibiotic Prophylaxis in Cleft Palate and Velopharyngeal Insufficiency RepairRecruitingNCT02688634Phase 4
2Botulinum Toxin to Improve Results in Cleft Lip RepairUnknown statusNCT01429402Phase 3
3Oral Cleft Prevention ProgramUnknown statusNCT00397917Phase 3
4Assessing the Results of Lip Surgery in Patients With Cleft Lip and PalateCompletedNCT00070811Phase 2, Phase 3
5Infra-orbital Nerve Block for Post Operative Analgesia in Children Undergoing Cleft Lip Surgery.CompletedNCT02514980Phase 2, Phase 3
6Oral Cleft Prevention Trial in BrazilCompletedNCT00098319Phase 3
7Comparative Study Between Levobupivacaine and Bupivacaine for Nerve Block During Pediatric Primary Cleft Palate SurgeryCompletedNCT02923869Phase 2, Phase 3
8Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainCompletedNCT00538850Phase 3
9External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain MetastasesUnknown statusNCT00637637Phase 2
10Cleft Palate Surgery and Speech DevelopmentCompletedNCT00004639Phase 2
11Cleft Orthognathic Surgery Versus Distraction Osteogenesis - Which is Better?CompletedNCT00930124Phase 2
12Improvement of the Appearance of Cleft Lip Scars Using BotoxRecruitingNCT02247193Phase 1, Phase 2
13Effect of Platelet Rich Plasma (PRP) on the Esthetic Outcome and Scar Formation of Unilateral Cleft Lip RepairNot yet recruitingNCT02958306Phase 2
14Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced CancerCompletedNCT00045006Phase 1
15Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced CancerCompletedNCT00036790Phase 1
16MS-275 in Treating Patients With Advanced Solid Tumors or LymphomaCompletedNCT00020579Phase 1
17Thalidomide and Docetaxel in Treating Patients With Advanced CancerCompletedNCT00049296Phase 1
18Use of Mesenchymal Stem Cells for Alveolar Bone Tissue Engineering for Cleft Lip and Palate PatientsUnknown statusNCT01932164
19Comparison of Two Nasoalveolar Molding Techniques in Complete Unilateral Cleft Lip PatientUnknown statusNCT01883726
20Osteogenesis and Dental Eruption Through Electrical StimuliUnknown statusNCT00975208
21One-Piece Le Fort I Osteotomy Versus Segmental Le Fort I OsteotomyUnknown statusNCT01871623
22FaceBase BiorepositoryUnknown statusNCT01252264
233D Imaging of Hard and Soft Tissue in Orthognathic SurgeryUnknown statusNCT00285714
24Articulation and Phonology in Children With Unilateral Cleft Lip and PalateCompletedNCT00829101
25A Study to Examine the Relationship Between Sleep Apnea and Cleft Lip/PalateCompletedNCT00156442
26Evaluation of Facial Growth in Two Primary Protocols Used in the Surgical Treatment of Unilateral Cleft Lip and Palate PatientsCompletedNCT02329509
27Effect Of Combination of Morphine+Fentanyl on Emergence Delirium in Patients of Cleft Lip and Palate RepairCompletedNCT03010540
28Primary Palatoplasty in Pediatric Patients - A Retrospective Review of Surgical OutcomesCompletedNCT01380171
29Tympanometric Analysis in Cleft PalateCompletedNCT01820689
30Systematic Pediatric Care for Oral Clefts - South AmericaCompletedNCT00097149
31Relational Development in Children With Cleft Lips and Palates: Influence of the Waiting Period Prior to the First Surgical Intervention and the Parents' Psychological Perception of the AbnormalityCompletedNCT00993993
32Svangerskap, Arv, og Miljo (Pregnancy, Heredity and Environment)CompletedNCT00340977
33Genetic Analysis of Fraser Syndrome and Fryns SyndromeCompletedNCT00032877
34Positive Exposure: A Photography and Video Intervention for Individuals With Craniofacial DifferencesCompletedNCT00340964
35Child's Adipose Cells: Capacity of Tissue RegenerationCompletedNCT02779205
36Study of the Experiences and Needs of Parents Continuing a Pregnancy Following a Prenatal Diagnosis of HolopresencephalyCompletedNCT00005016
37Sleep and Behavior in Children With Cleft PalateCompletedNCT01046591
38Genetic Analysis of Neural Tube and Orofacial Cleft Defects in the Irish PopulationCompletedNCT00341068
39Child and Infant Learning ProjectCompletedNCT00077831
40Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage CancerCompletedNCT00002520
41Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical TrialCompletedNCT00904514
42Clinical Effectiveness of Late Maxillary Protraction for Cleft Lip and PalateRecruitingNCT02789787
43Nasoalveolar Molding for Egyptian Cleft Lip Palate InfantsRecruitingNCT03029195
44Follow Ups of Parents With Infants With Cleft Lip and PalateRecruitingNCT02415361
45Biochemical and Histological Comparison of Nasal and Auricular Cartilage in the Fetus and Newborn With Cleft Lip CarrierRecruitingNCT02505360
46Prospective Data-collection System for the Comprehensive Appraisal of Cleft CareRecruitingNCT02702869
47Validation of a Production Method of Stem Cell Isolated From the Nasal Cavity for an Innovative Cell Therapy of Cleft PalateRecruitingNCT02900014
48Susceptibility Genes in Autism Spectrum DisordersRecruitingNCT02628808
49The Genetic Investigation of Reproductive Disorders (Including Kallmann Syndrome)RecruitingNCT01601171
50Alveolar Bone Grafting Outcome Between Patient With and Without Orthodontic TreatmentActive, not recruitingNCT02454998

Search NIH Clinical Center for Cleft Lip


Cochrane evidence based reviews: cleft lip

Genetic Tests for Cleft Lip

About this section

Anatomical Context for Cleft Lip

About this section

MalaCards organs/tissues related to Cleft Lip:

36
Bone, Brain, Heart, Liver, Skin, Kidney, Pituitary

Publications for Cleft Lip

About this section

Articles related to Cleft Lip:

(show top 50)    (show all 1127)
idTitleAuthorsYear
1
Assessment of complete unilateral cleft lip and palate patients: Determination of factors effecting dental arch relationships. (28012538)
2017
2
Intraflagellar transport 88 (IFT88) is crucial for craniofacial development in mice and is a candidate gene for human cleft lip and palate. (28069795)
2017
3
Evaluation of lip force in patients with unilateral and bilateral cleft lip. (28087210)
2017
4
International multiphase mixed methods study protocol to develop a cross-cultural patient-reported outcome instrument for children and young adults with cleft lip and/or palate (CLEFT-Q). (28077415)
2017
5
Comparing Modified Huddart-Bodenham Scoring System and GOSLON Yardstick to Assess Dental Arch Relationships in Unilateral Cleft Lip and Palate Patients. (28092164)
2017
6
Effect of Presurgical Nasoalveolar Molding on Nasal Symmetry in Unilateral Complete Cleft Lip/Palate Patients After Primary Cheiloplasty Without Concomitant Nasal Cartilage Dissection: Early Childhood Evaluation. (28085515)
2017
7
Skoog Primary Periosteoplasty versus Secondary Alveolar Bone Grafting in Unilateral Cleft Lip and Alveolus: Long-Term Effects on Alveolar Bone Formation and Maxillary Growth. (28027239)
2017
8
Dynamic facial asymmetry in patients with repaired cleft lip using 4D imaging (video stereophotogrammetry). (28011182)
2017
9
Genome-wide meta-analyses of nonsyndromic orofacial clefts identify novel associations between FOXE1 and all orofacial clefts, and TP63 and cleft lip with or without cleft palate. (28054174)
2017
10
Imputation of Orofacial Clefting Data Identifies Novel Risk Loci and Sheds Light on the Genetic Background of Cleft Lip A+ Cleft Palate and Cleft Palate Only. (28087736)
2017
11
The "Anatomical Balance Correction" for Secondary Cleft Lip Nasal Deformities. (28005768)
2016
12
MSX1 gene polymorphisms in Mexican patients with non-syndromic cleft lip/palate. (27729116)
2016
13
Sequence variation in folate pathway genes and risks of human cleft lip with or without cleft palate. (27604992)
2016
14
Association study between Van der Woude Syndrome causative gene GRHL3 and nonsyndromic cleft lip with or without cleft palate in a Chinese cohort. (27129939)
2016
15
Comparison of dental arch dimensions in models of preschool children with cleft lip/palate repaired by means of surgery alone versus controls. (27749647)
2016
16
Presurgical nasoalveolar moulding: A boon in the management of cleft lip and palate. (28050103)
2016
17
Computer-Assisted Orthognathic Surgery for Patients with Cleft Lip/Palate: From Traditional Planning to Three-Dimensional Surgical Simulation. (27002726)
2016
18
Five-year speech and language outcomes in children with cleft lip-palate. (27614545)
2016
19
Cleft Lip Repair: Through the Looking Glass. (28005748)
2016
20
Management of feeding Problem in a Patient with Cleft Lip/Palate. (27365936)
2016
21
Quantitative assessment of healthy and reconstructed cleft lip using ultrasonography. (27134448)
2016
22
Transforming Growth Factor Alpha Taq I Polymorphisms and Nonsyndromic Cleft Lip and/or Palate Risk: A Meta-Analysis. (28001102)
2016
23
Analysis of the maxillary dental arch after rapid maxillary expansion in patients with unilateral complete cleft lip and palate. (27131253)
2016
24
Policy on Management of Patients with Cleft Lip/Palate and Other Craniofacial Anomalies. (27931481)
2016
25
Chinese children with nonsyndromic cleft lip/palate: Factors associated with hearing disorder. (27497398)
2016
26
Measurement of Distraction Force in Cleft Lip and Palate Patients During Le Fort I Maxillary Advancement With Rigid External Distraction. (28027171)
2016
27
Unfavorable outcome of unilateral cleft lip repair. (27563597)
2016
28
Decolonisation of meticillin-resistant Staphylococcus aureus (MRSA) carriage in adopted children with cleft lip and palate. (27563747)
2016
29
Modified Activation Technique for Nasal Stent of Nasoalveolar Molding Appliance for Columellar Lengthening in Bilateral Cleft Lip/Palate. (27002917)
2016
30
Cleft sidedness and congenitally missing teeth in patients with cleft lip and palate patients. (27135068)
2016
31
Investigating Oral Microbiome Profiles in Children with Cleft Lip and Palate for Prognosis of Alveolar Bone Grafting. (27191390)
2016
32
Factors Affecting Length of Stay Cleft Lip Response. (27136072)
2016
33
Irf6 directly regulates Klf17 in zebrafish periderm and Klf4 in murine oral epithelium, and dominant-negative KLF4 variants are present in patients with cleft lip and palate. (26692521)
2016
34
Measuring Symmetry in Children With Cleft Lip. Part 3: Quantifying Nasal Symmetry and Nasal Normalcy Before and After Unilateral Cleft Lip Repair. (27580380)
2016
35
Suboptimal Performance in Cleft Lip/Palate Children- Who is Responsible? (27891420)
2016
36
Digital Three-Dimensional Automation of the Modified Huddart and Bodenham Scoring System for Patients With Cleft Lip and Palate. (27136074)
2016
37
Novel variant in the TP63 gene associated to ankyloblepharon-ectodermal dysplasia-cleft lip/palate (AEC) syndrome. (27485918)
2016
38
Assessing Angle's malocclusion among cleft lip and/or palate patients in Jammu. (27195223)
2016
39
Factors contributing to hearing impairment in patients with cleft lip/palate in Malaysia: A prospective study of 346 ears. (27497393)
2016
40
Recurrence of split hand/foot malformation, cleft lip/palate, and severe urogenital abnormalities due to germline mosaicism for TP63 mutation. (27351625)
2016
41
Fetal Cleft Lip/Palate Surgery: End of a Dream? (27115723)
2016
42
Electrophysiological assessment of auditory processing disorder in children with non-syndromic cleft lip and/or palate. (27635347)
2016
43
Two rare cases of simultaneous Tessier number 3 cleft, contralateral cleft lip, and signs of amniotic band syndrome. (27052637)
2016
44
Replantation of a displaced incisor in a boy with a cleft lip and alveolus: a case report. (27633512)
2016
45
Preliminary Analysis of the 3-Dimensional Morphology of the Upper Lip Configuration at the Completion of Facial Expressions in Healthy Japanese Young Adults and Patients With Cleft Lip. (27129635)
2016
46
Time trend of incidence rates of cleft lip/palate in Taiwan from 1994 to 2013. (27372171)
2016
47
Fordyce Happiness Program and Happiness in Mothers of Children with a Cleft Lip and Palate. (28008390)
2016
48
Presurgical Nasoalveolar Molding Therapy Using Figueroa's NAM Technique in Unilateral Cleft Lip and Palate Patients: A Preliminary Study. (27617383)
2016
49
MTR, MTRR, and MTHFR Gene Polymorphisms and Susceptibility to Nonsyndromic Cleft Lip With or Without Cleft Palate. (27167580)
2016
50
Nasoalveolar Molding Therapy for the Treatment of Unilateral Cleft Lip and Palate Improves Nasal Symmetry and Maxillary Alveolar Dimensions. (28005737)
2016

Variations for Cleft Lip

About this section

Expression for genes affiliated with Cleft Lip

About this section
Search GEO for disease gene expression data for Cleft Lip.

Pathways for genes affiliated with Cleft Lip

About this section

GO Terms for genes affiliated with Cleft Lip

About this section

Cellular components related to Cleft Lip according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1nucleusGO:00056347.2DLX4, FGFR1, IRF6, MSX1, PAX9, PHF8

Biological processes related to Cleft Lip according to GeneCards Suite gene sharing:

(show all 27)
idNameGO IDScoreTop Affiliating Genes
1keratinocyte proliferationGO:004361610.9IRF6, TP63
2BMP signaling pathway involved in heart developmentGO:006131210.9BMP4, MSX1
3epithelial to mesenchymal transition involved in endocardial cushion formationGO:000319810.9BMP4, MSX1
4anatomical structure formation involved in morphogenesisGO:004864610.9BMP4, TP63
5cloacal septationGO:006019710.9BMP4, TP63
6middle ear morphogenesisGO:004247410.9FGFR1, MSX1
7camera-type eye morphogenesisGO:004859310.8BMP4, NECTIN1
8positive regulation of collagen biosynthetic processGO:003296710.8BMP4, TGFB3
9positive regulation of SMAD protein import into nucleusGO:006039110.8BMP4, TGFB3
10organ inductionGO:000175910.8BMP4, FGFR1
11odontogenesis of dentin-containing toothGO:004247510.7BMP4, MSX1, TP63
12smooth muscle tissue developmentGO:004874510.6BMP4, TP63
13salivary gland morphogenesisGO:000743510.6FGFR1, TGFB3
14embryonic limb morphogenesisGO:003032610.5BMP4, FGFR1, MSX1, TP63
15face morphogenesisGO:006032510.5MSX1, PAX9, TGFB3
16positive regulation of bone mineralizationGO:003050110.5BMP4, TFAP2A, TGFB3
17regulation of odontogenesisGO:004248110.4MSX1, PAX9
18regulation of cell differentiationGO:004559510.2BMP4, FGFR1, TFAP2A
19odontogenesisGO:004247610.2BMP4, MSX1, PAX9, TGFB3
20negative regulation of apoptotic processGO:004306610.2BMP4, MSX1, TFAP2A, TGFA, TP63
21negative regulation of cell proliferationGO:000828510.2BMP4, IRF6, MSX1, TFAP2A, TGFB3
22palate developmentGO:006002110.0MSX1, SUMO1, TFAP2A, TGFB3, VAX1
23wound healingGO:00420609.9BMP4, TGFA, TGFB3
24positive regulation of transcription from RNA polymerase II promoterGO:00459449.7BMP4, MSX1, PAX9, TFAP2A, TGFB3, TP63
25negative regulation of transcription, DNA-templatedGO:00458929.7BMP4, MSX1, PAX9, SUMO1, TFAP2A, TP63
26positive regulation of transcription, DNA-templatedGO:00458939.7BMP4, IRF6, PHF8, TFAP2A, TGFB3, TP63
27negative regulation of transcription from RNA polymerase II promoterGO:00001229.5BMP4, DLX4, FGFR1, MSX1, TFAP2A, TP63

Sources for Cleft Lip

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet